Healthwell Acquisition Corp. I (HWEL)
Price:
10.47 USD
( + 0.01 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Centurion Acquisition Corp.
VALUE SCORE:
5
2nd position
Melar Acquisition Corp. I
VALUE SCORE:
11
The best
M3-Brigade Acquisition V Corp. Units
VALUE SCORE:
11
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
DESCRIPTION
Healthwell Acquisition Corp. I does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire technology-enabled companies in the healthcare industry. The company was incorporated in 2021 and is based in Winnetka, Illinois.
NEWS
Healthwell Acquisition Corp. I Announces Cancellation of Special Stockholder Meeting and its Intention to Liquidate
businesswire.com
2023-11-17 21:29:00WINNETKA, Ill.--(BUSINESS WIRE)--Healthwell Acquisition Corp. I (“Healthwell”) (Nasdaq: HWEL) announced today that (i) its previously announced special meeting of stockholders that was scheduled for December 4, 2023 has been cancelled, and that it has withdrawn from consideration by Healthwell's stockholders the proposals set forth in Heatlhwell's Definitive Proxy Statement on Schedule 14A filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 13, 2023 and (ii) it intend.
Healthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc.
businesswire.com
2023-11-03 19:00:00WINNETKA, Ill.--(BUSINESS WIRE)--Healthwell Acquisition Corp. I (“Healthwell”) (Nasdaq: HWEL) announced today that its previously announced Business Combination Agreement in connection with its planned business combination with Starton Therapeutics, Inc. (“Starton”) was terminated by Starton. The conditions to the closing of the initial business combination were not satisfied or waived by the outside date of November 3, 2023. As a result, Healthwell will seek an alternative business combination.
Starton Therapeutics Announces Termination of Business Combination Agreement with Healthwell Acquisition Corp. I
businesswire.com
2023-11-03 18:00:00PARAMUS, N.J.--(BUSINESS WIRE)--Starton Therapeutics Inc. (“Starton” or “the Company”), a clinical-stage biotechnology company focused on transforming standard-of-care therapies with proprietary continuous delivery technology, announced that it notified Healthwell Acquisition Corp. I (NASDAQ: HWEL) (“Healthwell”) today that the Company had elected to terminate the business combination agreement among Starton, Healthwell and the other parties thereto dated as of April 27, 2023, as amended (the “.
Healthwell Acquisition Corp. I Announces Postponement of the Special Meeting of Stockholders to Approve the Proposed Business Combination with Starton Therapeutics, Inc. and Related Transactions
businesswire.com
2023-10-23 23:55:00PARAMUS, N.J. & WINNETKA, Ill.--(BUSINESS WIRE)--Healthwell Acquisition Corp. I (“Healthwell,” “HWEL” or the “Company”) (NASDAQ: HWEL) announced today that it has postponed until further announcement the date of the special meeting of the Company's stockholders (the “Meeting”) to approve its proposed business combination with Starton Therapeutics, Inc. (“Starton”) and related transactions that had been scheduled for 10:00 a.m. Eastern Time on October 25, 2023. At the Meeting, the stockholders w.
Healthwell Acquisition Corp. I Announces New Meeting Date for the Special Meeting of Stockholders to Approve Proposed Business Combination With Starton Therapeutics, Inc. and Related Transactions
businesswire.com
2023-10-17 06:00:00PARAMUS, N.J. & WINNETKA, Ill.--(BUSINESS WIRE)--Healthwell Acquisition Corp. I (“Healthwell,” “HWEL” or the “Company”) (NASDAQ: HWEL) announced today that it has postponed the date of the special meeting of the Company's stockholders (the “Meeting”) to approve its proposed business combination with Starton Therapeutics, Inc. (“Starton”) and related transactions from the originally scheduled date of October 19, 2023. The new Meeting time and date will be 10:00 a.m. Eastern Time on October 25, 2.
No data to display
Healthwell Acquisition Corp. I Announces Cancellation of Special Stockholder Meeting and its Intention to Liquidate
businesswire.com
2023-11-17 21:29:00WINNETKA, Ill.--(BUSINESS WIRE)--Healthwell Acquisition Corp. I (“Healthwell”) (Nasdaq: HWEL) announced today that (i) its previously announced special meeting of stockholders that was scheduled for December 4, 2023 has been cancelled, and that it has withdrawn from consideration by Healthwell's stockholders the proposals set forth in Heatlhwell's Definitive Proxy Statement on Schedule 14A filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 13, 2023 and (ii) it intend.
Healthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc.
businesswire.com
2023-11-03 19:00:00WINNETKA, Ill.--(BUSINESS WIRE)--Healthwell Acquisition Corp. I (“Healthwell”) (Nasdaq: HWEL) announced today that its previously announced Business Combination Agreement in connection with its planned business combination with Starton Therapeutics, Inc. (“Starton”) was terminated by Starton. The conditions to the closing of the initial business combination were not satisfied or waived by the outside date of November 3, 2023. As a result, Healthwell will seek an alternative business combination.
Starton Therapeutics Announces Termination of Business Combination Agreement with Healthwell Acquisition Corp. I
businesswire.com
2023-11-03 18:00:00PARAMUS, N.J.--(BUSINESS WIRE)--Starton Therapeutics Inc. (“Starton” or “the Company”), a clinical-stage biotechnology company focused on transforming standard-of-care therapies with proprietary continuous delivery technology, announced that it notified Healthwell Acquisition Corp. I (NASDAQ: HWEL) (“Healthwell”) today that the Company had elected to terminate the business combination agreement among Starton, Healthwell and the other parties thereto dated as of April 27, 2023, as amended (the “.
Healthwell Acquisition Corp. I Announces Postponement of the Special Meeting of Stockholders to Approve the Proposed Business Combination with Starton Therapeutics, Inc. and Related Transactions
businesswire.com
2023-10-23 23:55:00PARAMUS, N.J. & WINNETKA, Ill.--(BUSINESS WIRE)--Healthwell Acquisition Corp. I (“Healthwell,” “HWEL” or the “Company”) (NASDAQ: HWEL) announced today that it has postponed until further announcement the date of the special meeting of the Company's stockholders (the “Meeting”) to approve its proposed business combination with Starton Therapeutics, Inc. (“Starton”) and related transactions that had been scheduled for 10:00 a.m. Eastern Time on October 25, 2023. At the Meeting, the stockholders w.
Healthwell Acquisition Corp. I Announces New Meeting Date for the Special Meeting of Stockholders to Approve Proposed Business Combination With Starton Therapeutics, Inc. and Related Transactions
businesswire.com
2023-10-17 06:00:00PARAMUS, N.J. & WINNETKA, Ill.--(BUSINESS WIRE)--Healthwell Acquisition Corp. I (“Healthwell,” “HWEL” or the “Company”) (NASDAQ: HWEL) announced today that it has postponed the date of the special meeting of the Company's stockholders (the “Meeting”) to approve its proposed business combination with Starton Therapeutics, Inc. (“Starton”) and related transactions from the originally scheduled date of October 19, 2023. The new Meeting time and date will be 10:00 a.m. Eastern Time on October 25, 2.